News | Mammography | February 28, 2018

Fujifilm Announces Nine Additional U.S. Installations of Aspire Cristalle With 3-D Mammography

Recent orders encompass 25 digital mammography systems from coast to coast

Fujifilm Announces Nine Additional U.S. Installations of Aspire Cristalle With 3-D Mammography

February 28, 2018 – Fujifilm Medical Systems U.S.A. Inc. announced nine of the initial healthcare systems across the United States that have selected its Aspire Cristalle mammography system with 3-D digital breast tomosynthesis (DBT) option to improve their diagnostic imaging capabilities and women’s health patient outcomes.

The  Aspire Cristalle with DBT combines Fujifilm’s Hexagonal Close Pattern (HCP) capture technology and intelligent image processing, optimizing dose and contrast based on individual breast composition. The result is low dose and fast acquisition of high-quality images for all breast types. In addition, patients can experience a noticeable improvement in comfort during procedures with Fujifilm’s patented, flexible comfort paddle design, which provides gentle and even compression that is designed to adapt to patient curves.

Recently, Fujifilm partnered with the following health providers for women’s health solutions:

  • Assured Imaging LLC (Tucson, Ariz.):  The provider of digital mammography spa-like standalone facilities and mobile coaches in the United States is installing 15 Aspire Cristalle units with DBT across the country.
  • Franklin Hospital (Benton, Ill.): A facility that provides patients in Benton and the surrounding rural areas with the best-quality healthcare in the region is planning to install its first Aspire Cristalle unit with DBT.
  • Little River Healthcare – King’s Daughters Clinic (Temple, Texas): A multi-specialty facility that has been serving the people of Temple, Killeen and Harker Heights for more than 80 years has recently installed its first Aspire Cristalle with DBT.
  • Morton General Hospital (Morton, Wash.): A 25-bed critical access hospital serving a 900-square-mile area and encompassing approximately 10,000 residents, is planning to install its first Aspire Cristalle with DBT.
  • Northern Radiology Imaging, PLLC (Watertown, N.Y.): The facility consisting of five staff radiologists with fellowships in neuroradiology, nuclear medicine, cross-sectional imaging and interventional radiology, has installed its first Aspire Cristalle with DBT.
  • Samaritan Medical Center (Watertown, N.Y.): A 294-bed community hospital, community healthcare clinics and satellite testing services, serving northern New York has installed three Aspire Cristalle units with DBT.
  • Self Regional Healthcare (Greenwood, South Carolina):  A major referral and medical center providing advanced healthcare services to a population of more than a quarter of a million people in the Lakelands region of upstate South Carolina is planning to install its first ASPIRE Cristalle unit with DBT.
  • Tiffany Breast Care Center (Youngstown, Ohio): The women’s health facility has installed its first Aspire Cristalle unit with DBT.
  • University Suburban Health Center (South Euclid, Ohio): Staffed by more than 140 physicians representing more than 30 medical specialties, University Suburban Health Center is equipped to offer the most complete and modern medical and surgical care available in a non-hospital environment. The facility installed its first Aspire Cristalle unit with DBT.

For more information: www.fujimed.com

 

Related Content

The Candelis ImageGrid Plus PACS Server is an ultra-high-performance platform that can support high volume healthcare environments of 1,000 plus modalities
News | PACS | February 12, 2020
February 12, 2020 — The Candelis ImageGrid Plus...
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
PaxeraHealth enterprise imaging, PACS, VNA solutions
News | Enterprise Imaging | February 11, 2020
February 11, 2020 — Enterprise Imaging developer PaxeraHealth
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du

Cloud-scale storage architecture is key to orchestrating highly secure, reliable and accessible data systems using affordable, efficient and sustainable approaches.

Feature | Information Technology | February 01, 2020 | By Tyna Callahan
In healthcare, critical systems are being used to deliver vital information and services 24/7/365.